Position in IMVT
as of Mar 31, 2026
· filed May 29, 2026
Position Value
$39,678,993
-$11,031,110 QoQ
Shares Held
1,597,383
-19.9% QoQ
Ownership
0.778%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMVT Over Time
Shares Held
Position Value (USD)
Derivatives in IMVT
reported options exposure · as of Jun 30, 2024CallValue
$5,280,000
CallShares
200,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026PERCEPTIVE ADVISORS LLC holds $4,580,660,548 across 68 Biotechnology names. IMVT ranks #26 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
2,035,986 | $655,974,329 | |
| 2 | CELC |
Celcuity Inc.
|
3,127,200 | $356,938,608 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,531,421 | $350,281,925 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
8,285,461 | $229,507,269 | |
| 5 | CNTA |
Centessa Pharmaceuticals plc
|
5,258,903 | $208,883,627 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,373,795 | $206,448,951 | |
| 7 | SYRE |
Spyre Therapeutics, Inc.
|
3,783,225 | $190,825,869 | |
| 8 | NUVL |
Nuvalent, Inc.
|
1,580,505 | $161,922,737 |
All Filings in IMVT
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $39,678,993 | 1,597,383 | Shares | Sole | 2026-05-29 | |
| 2025-12-31 | $50,710,103 | 1,994,890 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $25,596,786 | 1,587,890 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $34,206,240 | 2,137,890 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $48,605,190 | 2,844,072 | Shares | Sole | 2025-08-06 | |
| 2024-12-31 | $52,987,959 | 2,139,199 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $67,818,504 | 2,378,762 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,280,000 | 200,000 | Call | Sole | 2024-08-16 | |
| 2024-06-30 | $50,787,950 | 1,923,786 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $95,741,379 | 2,963,212 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $3,231,000 | 100,000 | Call | Sole | 2024-08-06 | |
| 2023-12-31 | $98,082,094 | 2,328,082 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $146,445,987 | 3,814,691 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $47,876,163 | 2,523,783 | Shares | Sole | 2023-08-24 | |
| 2023-03-31 | $20,036,717 | 1,291,858 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $2,662,500 | 150,000 | Shares | Sole | 2023-02-14 | |
| 2020-12-31 | $64,666,000 | 1,400,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $49,266,000 | 1,400,000 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $26,785,000 | 1,100,000 | Shares | Sole | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||